|
US2020277323A1
|
|
MORPHIC FORMS OF 4-AMINO-7-(3,4-DIHYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-2-METHYL-7H-PYRROLO[2,3-d]PYRIMIDINE-5-CARBOXAMIDE AND USES THEREOF
|
|
WO2018156879A1
|
|
Treatment of adenovirus with brincidofovir
|
|
CA3024886A1
|
|
Formulations of brincidofovir
|
|
MX2018001073A
|
|
Pyrrolopyrimidine nucleosides and analogs thereof useful as antiviral agents.
|
|
AU2015264949A1
|
|
Composition and methods of treating viral infections and viral induced tumors
|
|
AU2015203573A1
|
|
Methods of treating viral associated diseases
|
|
AU2015201895A1
|
|
Phosphonate ester derivatives and methods of synthesis thereof
|
|
CN106061982A
|
|
Branched chain acyclic nucleoside phosphonate esters and methods of synthesis and uses thereof
|
|
KR20170143009A
|
|
Morphic forms of hexadecyloxypropyl-phosphonate esters
|
|
CN108210502A
|
|
Treat the method for retroviral infection and relevant dose scheme
|
|
US2015087619A1
|
|
Method of mitigating virus associated end-organ damage
|
|
CA2853720A1
|
|
Hexadecyloxypropyl cidofovir for the treatment of double-stranded dna virus infection
|
|
CN105218580A
|
|
Phosphate derivatives and synthetic method thereof
|
|
AU2011248620A1
|
|
Methods of treating retroviral infections and related dosage regimes
|
|
US2011263536A1
|
|
Methods of Treating Orthopox Virus Infections and Associated Diseases
|
|
HUE032860T2
|
|
Methods of treating viral infection
|
|
CN102665729A
|
|
Methods of treating viral associated diseases
|
|
AU2010313273A1
|
|
Methods of treating viral associated diseases
|
|
WO2011017253A1
|
|
Composition and methods of treating viral infections and viral induced tumors
|
|
WO2011011519A1
|
|
Compounds, compositions and methods for treating ocular conditions
|
